查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1931219

胃造瘻管市场（按产品类型、应用、最终用户和分销管道划分），全球预测（2026-2032年）

Gastric or Gastrostomy Tubes Market by Product Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年胃造瘻管市场价值为 24.1 亿美元，预计到 2026 年将成长至 25.1 亿美元，年复合成长率为 5.45%，到 2032 年将达到 34.9 亿美元。

关键市场统计数据
基准年 2025 24.1亿美元
预计年份：2026年 25.1亿美元
预测年份 2032 34.9亿美元
复合年增长率 (%) 5.45%

简要概述了正在重塑医疗保健领域胃管或胃造瘻管使用的临床需求、设备发展和相关人员的优先事项。

胃造瘻管仍然是现代经肠营养治疗的基础组成部分，支持从短期减压到长期营养治疗等多种临床目标。器械设计和置入技术的进步拓展了治疗选择，同时，住院和门诊患者对安全性、舒适度和易用性的期望也日益提高。临床医生、供应链负责人和器械製造商正围绕通用的目标开展合作：最大限度地降低併发症发生率，简化置入和维护流程，并提供既能保证医疗品质又经济高效的解决方案。

临床、技术和营运因素驱动的重大变革正在重新定义肠内营养治疗中的设备选择、护理路径和给药方式。

随着临床、技术和操作趋势的融合，胃造瘻管领域正经历变革性的转变。微创置入技术和更细器械的普及正在重新定义术后护理，促进患者更早从急性期护理过渡到门诊和家庭护理。同时，材料创新和改进的固定机制正在减少器械相关併发症，这正在影响临床医生的选择和医疗机构的筹资策略。

评估2025年对肠内营养输注装置生产征收关税的累积营运和策略影响（供应链、筹资策略和成本动态）。

2025年实施的新关税措施对胃造瘻管产业的相关人员产生了重大的营运和策略影响。由于关税上调和相关的物流成本上涨，依赖进口的零件，例如特殊聚合物、硅化合物和某些生产设备，其到岸成本均增加。依赖跨境供应链的製造商正在调整筹资策略，包括利用区域供应商和探索替代的原材料规格，以降低关税波动带来的风险。

透过整合产品系列、临床应用、使用者环境和通路，进行综合細項分析，为采购和临床通讯协定决策提供支援。

该领域的产品细分涵盖了不同的器材系列，以满足各种临床场景和患者需求。器械可分为低轮廓设计、经皮视镜系统和放射介入器。在低轮廓设计类别中，製造商区分球囊固定係统和缓衝垫固定係统，球囊固定係统又可进一步分为一次性使用和可重复填充两种，以适应一次性使用通讯协定或长期治疗。同样，经皮视镜产品也提供球囊固定或缓衝垫固定两种选择，以满足临床医师的偏好和解剖结构方面的考虑；放射介入器材也采用类似的固定方式，以适应影像引导下的置入流程。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势和差异化应用模式影响供应、监管和临床应用策略。

区域趋势揭示了影响美洲、欧洲、中东和非洲以及亚太地区设备选择、供应链策略和临床实践应用的不同驱动因素和采用模式。在美洲，采用趋势是由更新的临床指南、报销框架以及众多重症监护机构优先选择有助于缩短住院时间和减少术后併发症的设备等因素共同驱动的。因此，该地区的采购团队优先考虑临床证据、供应商可靠性以及与现有肠内治疗工作流程的整合。

为确保肠内营养疗法的长期应用，竞争定位和企业策略强调创新、实证伙伴关係和供应稳定性。

胃造瘻管市场的竞争格局以产品创新、生产规模以及透过证据证明其临床性能的能力为特征。领先的医疗器材製造商透过投资材料研发来提高生物相容性和耐用性，改善固定机制以减少併发症，并提升易用性以支持临床医生快速采纳和居家安全使用，从而保持竞争优势。

製造商和医疗保健领导者应重点关注以下切实可行的策略事项：整合创新、供应链韧性和临床医生支持，以实现持续应用并改善患者疗效。

产业领导者应采取协作策略，将产品创新、供应链韧性和以临床医生为中心的服务相结合，以最大限度地提高产品普及率和患者疗效。优先投资于能够直接降低併发症率、简化植入和维护的设备功能，从而解决临床医生和看护者面临的关键挑战。同时，应透过全面的培训计画和数位化赋能工具来完善产品开发，以加速临床医生的熟练度提升，并确保患者能够安全地在家中进行长期治疗。

采用严谨的混合方法调查方法，结合临床访谈、监管分析、技术评估和通路分析，以产生可操作的洞见。

本调查方法结合了结构化的初步研究、严谨的二次研究和系统性的综合分析，以确保研究结果能反映实际临床实践和当前的监管环境。初步研究包括对医院、门诊和居家医疗机构的临床医生进行访谈；与采购和供应链专业人员进行讨论；以及与医疗器械工程师进行咨询，以了解设计限制和製造方面的考虑因素。这些面对面的交流能够提供关于医疗器材性能、培训需求和推广应用障碍的定性见解。

整合临床、营运和策略方面的结论，以促进实证应用、供应稳定和以使用者为中心的医疗设备设计。

胃造瘻管或胃管仍是重要的临床工具，其有效性取决于器械设计、临床医生技能和稳健的供应模式的综合考虑。新型器械的创新和改进的手术流程有助于更安全地过渡到门诊和居家照护，而日益严格的监管审查和关税趋势正在推动更具策略性的供应链配置。优先考虑临床证据、多元化供应来源和终端用户支援的相关人员将更有能力应对营运压力并改善患者预后。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的胃管或胃造瘻管市场

  • 经皮视镜
  • 放射插入

9. 依应用分類的胃管或胃造瘻管市场

  • 引流
    • 胃减压
    • 胃内容物采集
  • 药物管理
    • 液体药物
    • 粉状药物
  • 营养补充
    • Bolus餵
    • 持续的营养支持

10. 依最终使用者分類的胃造瘻管或胃管市场

  • 门诊手术中心
  • 居家医疗
    • 护理服务
    • 自我管理
  • 医院

11. 依分销管道分類的胃造瘻管市场

  • 离线
  • 在线的

12. 各地区胃造瘻管市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

13. 依组别分類的胃造瘻管或胃管市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各国胃造瘻管市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国胃造瘻管市场

16. 中国：胃造瘻管市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Amsino International, Inc.
  • Applied Medical Technology, Inc.
  • Avanos Medical, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Coloplast A/S
  • CONMED Corporation
  • ConvaTec Group PLC
  • Cook Medical Incorporated
  • Danone SA
  • Fresenius Kabi AG
  • Halyard Health, Inc.
  • Hollister Incorporated
  • Kimberly-Clark Corporation
  • Mead Johnson Nutrition Company
  • Medtronic plc
  • Moog Inc.
  • Nestle Health Science
  • Smiths Medical
  • Vygon SA
Product Code: MRR-7B550E008DC7

The Gastric or Gastrostomy Tubes Market was valued at USD 2.41 billion in 2025 and is projected to grow to USD 2.51 billion in 2026, with a CAGR of 5.45%, reaching USD 3.49 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.41 billion
Estimated Year [2026] USD 2.51 billion
Forecast Year [2032] USD 3.49 billion
CAGR (%) 5.45%

A concise orientation explaining clinical imperatives, device evolution, and stakeholder priorities reshaping gastric and gastrostomy tube utilization across care settings

Gastric and gastrostomy tubing remains a foundational component of modern enteral care, supporting diverse clinical objectives from short-term decompression to long-term nutritional therapy. Advances in device design and insertion techniques have expanded therapeutic options while elevating expectations for safety, patient comfort, and usability across inpatient and outpatient settings. Clinicians, supply chain leaders, and device manufacturers are convening around common priorities: minimizing complication rates, streamlining insertion and maintenance workflows, and delivering cost-efficient solutions that preserve quality of care.

Over the past decade, incremental innovation in materials science, retention mechanisms, and low-profile form factors has altered procurement criteria and clinical protocols. Simultaneously, regulatory scrutiny and reimbursement considerations have prompted more rigorous evidence generation and post-market surveillance. This combination of clinical demand and regulatory pressure has accelerated adoption of devices that demonstrably reduce adverse events and decrease caregiver burden. Consequently, decision-makers are evaluating devices not only on product specifications but also on training requirements, compatibility with existing inventory, and the ability of suppliers to guarantee consistent quality and timely delivery.

Key transformative shifts driven by clinical, technological, and operational forces that are redefining device selection, care pathways, and supply approaches in enteral access therapy

The landscape for gastric and gastrostomy tubes is undergoing transformative shifts driven by converging clinical, technological, and operational trends. Minimally invasive insertion techniques and expanded use of low-profile devices are redefining post-procedure management, encouraging earlier transitions from acute care to outpatient and home-based therapy. Concurrently, material innovations and improved retention mechanisms are reducing device-related complications, which in turn influences clinician preferences and institutional procurement strategies.

Operational pressures within hospitals and ambulatory centers are prompting greater emphasis on product standardization and supplier consolidation to achieve predictable inventory turnover and simplified clinician training. At the same time, the rise of telehealth-enabled home healthcare monitoring and more robust caregiver education programs is supporting safe long-term gastrostomy care outside hospital walls. Moreover, heightened regulatory attention to device labeling and adverse event reporting is encouraging manufacturers to invest in clinical evidence and quality systems, thus raising the bar for market entry and reinforcing the competitive advantage of established players with proven compliance capabilities.

Assessing the cumulative operational and strategic effects of 2025 tariff measures on supply chains, sourcing strategies, and cost dynamics within enteral access device production

The implementation of new tariff measures in 2025 has created material operational and strategic implications for stakeholders in the gastric and gastrostomy tubes space. Import-sensitive components such as specialized polymers, silicone compounds, and certain manufacturing equipment have experienced elevated landed costs due to increased duties and associated logistical premiums. Manufacturers that rely on cross-border supply chains have adjusted sourcing strategies, seeking regional suppliers or alternative input specifications to mitigate exposure to tariff volatility.

In response, device producers have pursued several adaptation pathways. Some have localized critical manufacturing steps or established regional assembly hubs to preserve competitiveness and shorten inbound lead times. Others have restructured supplier contracts to shift cost-sharing dynamics or accelerated qualification of alternative materials that meet clinical and regulatory benchmarks. For purchasers, procurement cycles now incorporate tariff impact assessments when evaluating total cost of ownership and long-term vendor relationships. Healthcare providers and group purchasing organizations are increasingly requesting transparency on tariff-related cost components and supplier resilience plans to ensure continuity of care and to avoid unforeseen budgetary pressures.

Furthermore, tariff-driven cost adjustments have incentivized efficiency gains across manufacturing and distribution, prompting investments in automation, process optimization, and inventory management technologies. These operational responses aim to offset tariff-induced input cost increases while preserving product quality and maintaining access across care settings. As a result, stakeholders who proactively addressed tariff exposure through supply diversification and process improvements are better positioned to sustain service levels and manage procurement predictably.

Integrated segmentation analysis linking product families, clinical applications, user environments, and distribution pathways to inform procurement and clinical protocol decisions

Product segmentation in this sector encompasses distinct device families that align with varied clinical scenarios and patient needs. Devices are grouped under low-profile designs, percutaneous endoscopic systems, and radiologically inserted devices. Within the low-profile category, manufacturers differentiate between balloon retention and bumper retention modalities, with balloon variants further divided into one-time and refillable options to support single-use protocols or longer-term therapy. Similarly, percutaneous endoscopic products are available with either balloon or bumper retention to accommodate clinician preference and anatomical considerations, and radiologically inserted devices mirror these retention configurations to suit image-guided placement workflows.

Applications for these devices span drainage, medication administration, and nutrition delivery, reflecting the procedural and therapeutic breadth of enteral access. Drainage use cases include gastric decompression and gastric sampling, each carrying specific design and handling requirements. Medication administration spans liquid and powdered formulations, driving requirements for lumen size, port design, and flushing protocols. Nutrition delivery differentiates between bolus feeding and continuous feeding regimens, which influence tube diameter, material resilience, and compatibility with feeding pumps.

End users range from ambulatory surgical centers and home healthcare settings to hospital environments, each imposing unique operational constraints and service expectations. Ambulatory surgical centers include day surgery centers and outpatient clinics where rapid turnover and simple device handling are prioritized. Home healthcare encompasses nursing service support and self-administration contexts, emphasizing ease of use, caregiver training, and remote support. Hospitals cover both secondary and tertiary care facilities with diverse procedural volumes and complexity profiles.

Distribution channels shape product accessibility and procurement cadence through direct tenders, distributor networks, and online platforms. Distributors include local wholesalers and specialized medical distributors that provide logistical reach and inventory services, while online channels encompass e-commerce vendors and original equipment manufacturer platforms that offer direct access and digital ordering convenience. The interplay of product features, clinical applications, user environment, and distribution pathways informs purchasing decisions, clinical guidelines, and supplier selection processes, requiring an integrated assessment when evaluating new device introductions or standardizing formularies.

Regional dynamics and differentiated adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific that inform supply, regulation, and clinical adoption strategies

Regional trends demonstrate distinct drivers and adoption patterns across the Americas, Europe, Middle East & Africa, and Asia-Pacific regions that influence device selection, supply chain strategies, and clinical practice adoption. In the Americas, adoption is often guided by a combination of clinical guideline updates, reimbursement frameworks, and a concentration of advanced acute care centers that favor devices reducing length of stay and post-procedure complications. Consequently, procurement teams in this region emphasize clinical evidence, supplier reliability, and integration with existing enteral therapy workflows.

In Europe, Middle East & Africa, regulatory harmonization efforts and cross-border procurement practices influence manufacturer strategies, with larger health systems and national procurement bodies seeking long-term supplier partnerships and consistent quality standards. Variability in healthcare infrastructure across this combined region creates demand for both high-end specialty devices suited for tertiary centers and cost-effective solutions tailored to resource-constrained settings. This dynamic stimulates product tiering and adaptable device portfolios.

Asia-Pacific exhibits rapid adoption of minimally invasive techniques and growing investment in outpatient and home-based care infrastructure. Manufacturer investments in regional production and distribution hubs are common to address logistical complexities and to shorten lead times. Across all regions, local clinical training programs, regulatory requirements, and supply chain resilience considerations shape uptake patterns, highlighting the need for manufacturers to align product design and commercial strategies with regional clinical workflows and procurement expectations.

Competitive positioning and corporate strategies emphasizing innovation, evidence partnerships, and supply resilience to secure long-term adoption in enteral access therapy

Competitive dynamics in the gastric and gastrostomy tubes landscape are characterized by product innovation, manufacturing scale, and the ability to demonstrate clinical performance through evidence generation. Leading device manufacturers maintain competitive advantage by investing in materials research to improve biocompatibility and durability, refining retention mechanisms to reduce complications, and enhancing usability features that support rapid clinician adoption and safe home use.

Partnerships between device companies and clinical centers have become an important pathway for iterative product improvement and real-world evidence collection. These collaborations support post-market surveillance and comparative performance assessments, informing labeling updates and clinician training programs. Additionally, strategic alliances with distribution partners and healthcare systems enable efficient inventory management and broaden access in outpatient and home settings.

Supply chain resilience and regulatory compliance are increasingly central to competitive positioning. Firms that have diversified component sourcing, developed regional manufacturing footprints, and implemented robust quality management systems are better equipped to manage disruptions and meet diverse regulatory requirements. Finally, companies that offer integrated service packages-including clinician training, remote monitoring tools, and comprehensive warranty and support programs-tend to achieve stronger uptake among hospitals, ambulatory centers, and home healthcare providers who value total cost of care and patient safety outcomes.

Actionable strategic priorities for manufacturers and healthcare leaders to align innovation, supply resilience, and clinician support for sustainable adoption and improved outcomes

Industry leaders should pursue a coordinated strategy that aligns product innovation with supply chain resilience and clinician-focused services to maximize adoption and patient outcomes. Prioritize investments in device features that directly reduce complication rates and simplify insertion and maintenance, thereby addressing the primary clinician and caregiver pain points. Complement product development with comprehensive training programs and digital support tools that accelerate clinician proficiency and enable safe home-based management of long-term therapies.

Strengthen supplier networks by qualifying alternative material sources and establishing regional assembly or finishing capabilities to reduce tariff exposure and shorten delivery timelines. Contractual frameworks that emphasize transparency on cost drivers and contingency planning will support stronger procurement relationships with healthcare systems. Additionally, cultivating partnerships with leading clinical centers to generate real-world evidence and post-market safety data enhances credibility and supports adoption across a broader range of care settings. Finally, design commercial models that accommodate diverse procurement channels-from direct tenders to e-commerce platforms-while offering configurable service tiers to meet the needs of tertiary hospitals, ambulatory centers, and home healthcare providers.

A rigorous mixed-methods research approach combining clinical interviews, regulatory analysis, technical review, and distribution channel mapping to produce actionable intelligence

The research methodology combines structured primary engagements, rigorous secondary review, and systematic synthesis to ensure findings reflect practical clinical realities and current regulatory landscapes. Primary inputs include interviews with clinicians across hospital, ambulatory, and home healthcare environments, discussions with procurement and supply chain professionals, and consultations with device engineers to understand design constraints and manufacturing considerations. These direct interactions provide qualitative insights into device performance, training needs, and adoption barriers.

Secondary analysis encompassed a comprehensive review of regulatory guidance documents, clinical practice guidelines, and device labeling to contextualize safety expectations and compliance trends. Patent literature and technical specifications were examined to identify material and design innovations. Distribution channel dynamics were analyzed through supplier network mapping and platform capability assessments to understand how access and procurement pathways vary by region. Throughout the process, data integrity was assured via triangulation across sources and validation checkpoints with industry experts, enabling a robust synthesis that supports actionable recommendations for stakeholders.

Synthesis of clinical, operational, and strategic conclusions emphasizing evidence-driven adoption, supply stability, and user-centered device design

Gastric and gastrostomy tubes remain essential clinical tools whose effectiveness depends on the confluence of device design, clinician competency, and resilient supply models. Emerging device innovations and procedural refinements are enabling safer transitions to outpatient and home-based care, while regulatory scrutiny and tariff dynamics are prompting more strategic supply chain configurations. Stakeholders that prioritize clinical evidence, supply diversification, and end-user support will be better positioned to navigate operational pressures and to improve patient outcomes.

Decision-makers should view device selection through a systems lens that accounts for insertion workflows, post-procedural care, caregiver capabilities, and distribution reliability. By aligning product portfolios with clinical needs and by investing in training and service infrastructure, manufacturers and providers can reduce complications, streamline care pathways, and expand access to appropriate enteral therapies. In summary, the sector's near-term trajectory favors practical innovations that deliver measurable improvements in safety, usability, and operational predictability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastric or Gastrostomy Tubes Market, by Product Type

  • 8.1. Percutaneous Endoscopic
  • 8.2. Radiologically Inserted

9. Gastric or Gastrostomy Tubes Market, by Application

  • 9.1. Drainage
    • 9.1.1. Gastric Decompression
    • 9.1.2. Gastric Sampling
  • 9.2. Medication Administration
    • 9.2.1. Liquid Medication
    • 9.2.2. Powdered Medication
  • 9.3. Nutrition
    • 9.3.1. Bolus Feeding
    • 9.3.2. Continuous Feeding

10. Gastric or Gastrostomy Tubes Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Home Healthcare
    • 10.2.1. Nursing Service
    • 10.2.2. Self Administration
  • 10.3. Hospitals

11. Gastric or Gastrostomy Tubes Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Gastric or Gastrostomy Tubes Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Gastric or Gastrostomy Tubes Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Gastric or Gastrostomy Tubes Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Gastric or Gastrostomy Tubes Market

16. China Gastric or Gastrostomy Tubes Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Amsino International, Inc.
  • 17.7. Applied Medical Technology, Inc.
  • 17.8. Avanos Medical, Inc.
  • 17.9. B. Braun Melsungen AG
  • 17.10. Baxter International Inc.
  • 17.11. Becton, Dickinson and Company
  • 17.12. Boston Scientific Corporation
  • 17.13. Cardinal Health, Inc.
  • 17.14. Coloplast A/S
  • 17.15. CONMED Corporation
  • 17.16. ConvaTec Group PLC
  • 17.17. Cook Medical Incorporated
  • 17.18. Danone S.A.
  • 17.19. Fresenius Kabi AG
  • 17.20. Halyard Health, Inc.
  • 17.21. Hollister Incorporated
  • 17.22. Kimberly-Clark Corporation
  • 17.23. Mead Johnson Nutrition Company
  • 17.24. Medtronic plc
  • 17.25. Moog Inc.
  • 17.26. Nestle Health Science
  • 17.27. Smiths Medical
  • 17.28. Vygon S.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY RADIOLOGICALLY INSERTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY RADIOLOGICALLY INSERTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY RADIOLOGICALLY INSERTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY GASTRIC DECOMPRESSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY GASTRIC DECOMPRESSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY GASTRIC DECOMPRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY GASTRIC SAMPLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY GASTRIC SAMPLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY GASTRIC SAMPLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY LIQUID MEDICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY LIQUID MEDICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY LIQUID MEDICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY POWDERED MEDICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY POWDERED MEDICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY POWDERED MEDICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY BOLUS FEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY BOLUS FEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY BOLUS FEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY CONTINUOUS FEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY CONTINUOUS FEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY CONTINUOUS FEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NURSING SERVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NURSING SERVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NURSING SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY SELF ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY SELF ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. GCC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GCC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. GCC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 152. GCC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 153. GCC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. GCC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 155. GCC GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. G7 GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. G7 GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. G7 GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. G7 GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 179. G7 GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 180. G7 GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. G7 GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 182. G7 GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. NATO GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. NATO GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. NATO GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. NATO GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 187. NATO GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 188. NATO GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 189. NATO GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. NATO GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 191. NATO GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY MEDICATION ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA GASTRIC OR GASTROSTOMY TUBES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)